The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. ANIXA BIOSCIENCES INC (ANIX) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question.ANIXA BIOSCIENCES INC is one of 987 companies in the Medical group. The Medi ...

Investors interested in Medical stocks should always be looking to find the best-performing companies in the group. Has Gilead Sciences (GILD) been one of those stocks this year? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question.Gilead Sciences is a member of the Medical sector. This group includes 987 individual stocks and currently holds a Zacks Sector Rank of #5. The Zacks Sector Rank considers 16 different sector groups. ...

CRISPR Therapeutics AG (CRSP) ended the recent trading session at $51.19, demonstrating a -1.88% change from the preceding day's closing price. This move lagged the S&P 500's daily loss of 0.79%. Meanwhile, the Dow lost 0.94%, and the Nasdaq, a tech-heavy index, lost 0.92%. The stock of company has risen by 24.63% in the past month, leading the Medical sector's gain of 1.49% and the S&P 500's gain of 5.22%.Market participants will be closely following the financial results of CRISPR Therapeutics AG in its u ...

Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Kamada (KMDA) and Acadia Pharmaceuticals (ACAD) . But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer look.We have found that the best way to discover great value opportunities is to pair a strong Zacks Rank with a great grade in the Value category of our Style Scores system. The Zacks Rank favors stocks with strong earnings estimate revision trends, ...

For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Is Adaptive Biotechnologies (ADPT) one of those stocks right now? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question.Adaptive Biotechnologies is one of 987 companies in the Medical group. The Medical group currently sits at #6 within the Zacks Sector Rank. The Zacks Sector Rank considers 16 d ...

In the latest trading session, Recursion Pharmaceuticals (RXRX) closed at $5.27, marking a +1.15% move from the previous day. The stock's performance was ahead of the S&P 500's daily gain of 0.83%. At the same time, the Dow added 0.77%, and the tech-heavy Nasdaq gained 1.02%. The biotechnology company's shares have seen an increase of 6.11% over the last month, surpassing the Medical sector's gain of 2.2% and the S&P 500's gain of 4.99%.The upcoming earnings release of Recursion Pharmaceuticals will be of g ...

Wall Street expects a year-over-year increase in earnings on higher revenues when Nurix Therapeutics, Inc. (NRIX) reports results for the quarter ended May 2025. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.The stock might move higher if these key numbers top expectations in the upcoming earnings report. On the other hand, if they miss, the s ...

The volatile biotech industry has braved the global trade war relatively well in the first half of 2025. While a pause in the tariff war between the United States and China has lent some stability, ongoing geopolitical tensions continue to be a headwind. Nonetheless, given the continuous need for innovative medical treatments (regardless of the state of the economy), the dynamic biotech industry will continue to capture investors’ interest despite the inherent volatility and uncertain macroeconomic environm ...

Astrazeneca (AZN) closed the most recent trading day at $71.46, moving +2.26% from the previous trading session. The stock's performance was ahead of the S&P 500's daily loss of 0.11%. Elsewhere, the Dow saw an upswing of 0.91%, while the tech-heavy Nasdaq depreciated by 0.82%. Shares of the pharmaceutical have depreciated by 2.85% over the course of the past month, underperforming the Medical sector's gain of 1.66%, and the S&P 500's gain of 5.17%.Investors will be eagerly watching for the performance of A ...

Immunome, Inc. (IMNM) shares rallied 6% in the last trading session to close at $9.3. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 0.1% gain over the past four weeks.The sudden price rise can be attributed to growing investor optimism regarding the company’s efforts to develop its lead pipeline candidate, varegacestat, which is currently in late-stage clinical studies for the treatment of desmoid tumors. I ...